Ensayo clínico

C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study.

NCT: NCT03311451 · ACTIVE_NOT_RECRUITING

ID NCTNCT03311451

EstadoACTIVE_NOT_RECRUITING

Fecha de inicio2023-01-16

Finalización2026-12-18

SponsorMerit Medical Systems, Inc. (INDUSTRY)

First posted2017-10-17

Last updated2026-05-22

Resumen breve

The primary objective is to determine the safety and efficacy of the C2 CryoBalloon 180 Ablation System ("CryoBalloon 180") used at decreasing doses in ablation naïve patients with low- or high-grade dysplastic Barrett's Esophagus (BE) or with residual BE after resection of dysplasia or early adenocarcinoma.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.